Han, X. (2022) “Dexmedetomidine reduces dextran sulfate sodium (DSS)-induced NCM460 cell inflammation and barrier damage by inhibiting RhoA/ROCK signaling pathway”, Allergologia et Immunopathologia, 50(3), pp. 85–92. doi:10.15586/aei.v50i3.569.